Segment Information

12 Months Ended

Dec. 31, 2019

Note 15—Segment Information

The Company has organized its business into two operating segments based on the product specialties: the vascular segment and the dermatology segment.

In deciding how to allocate resources and assess performance, the Company’s chief operating decision maker regularly evaluates the sales and gross profit of these segments. Amounts included within selling, general and administrative expense and research and development expense are general to the Company and not specific to a particular segment; therefore, these amounts are not evaluated by the Company’s chief operating decision maker on a segmented basis.

The following tables summarize segment performance (in thousands):

	Year Ended December 31,
	2019			2018
Vascular	$	1,275		$	1,552
Dermatology		5,924			4,705
Net revenue	$	7,199		$	6,257
Vascular	$	4,036		$	1,521
Dermatology		4,814			2,685
Cost of revenue	$	8,850		$	4,206
Vascular	$	(2,761	)	$	31
Dermatology		1,110			2,020
Gross (loss) profit	$	(1,651	)	$	2,051

Generally, all assets are common assets, except for lasers, which are a subset of property and equipment. The net book value of the lasers aggregated in the vascular segment was $2.6 million and $2.2 million as of December 31, 2019 and 2018, respectively. The net book value of the lasers placed with customers aggregated in the dermatology segment was $0.9 million and $0.7 million as of December 31, 2019 and 2018, respectively.

Net revenue, classified by the major geographic areas in which our customers are located, was as follows (in thousands):

	Year Ended December 31,
	2019		2018
United States	$	6,568	$	5,835
All other countries		631		422
Net revenue	$	7,199	$	6,257